Michael S Perry Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Michael S Perry is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 114,754 shares of ARWR, which is worth approximately $2.24 Million. The most recent transaction as insider was on Dec 15, 2023, when has been sold 14,987 shares (Common Stock) at a price of $25.41 per share, resulting in proceeds of $380,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 115K
0% 3M change
15.02% 12M change
Total Value Held $2.24 Million

MICHAEL S PERRY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2023
BUY
Grant, award, or other acquisition
$380,819 $25.41 p/Share
14,987 Added 11.55%
114,754 Common Stock
Jan 10 2023
BUY
Grant, award, or other acquisition
-
7,867 Added 7.31%
99,767 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
6,400 Added 6.51%
91,900 Common Stock
Jan 03 2022
SELL
Open market or private sale
$293,490 $65.22 p/Share
4,500 Reduced 5.0%
85,500 Common Stock
Jan 04 2021
SELL
Open market or private sale
$304,360 $76.09 p/Share
4,000 Reduced 4.26%
90,000 Common Stock Sold
Jan 01 2021
BUY
Grant, award, or other acquisition
-
9,000 Added 8.74%
94,000 Common Stock

Also insider at

RCEL
AVITA Medical, Inc. Healthcare
Director
MSP

Michael S Perry

Director
Valencia, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR